Literature DB >> 3929150

Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy.

J Sasaki, F Hara, T Motooka, S Naito, K Arakawa.   

Abstract

We describe a case of nephrotic syndrome (idiopathic membranous glomerulonephropathy) with high serum HDL cholesterol (91 mg/100 ml) which increased to 240 mg/100 ml following steroid therapy. The increase in HDL was mainly a result of increased HDL2 and increased plasma apolipoprotein A-I.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3929150     DOI： 10.1159/000183556

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


  3 in total

1.  Effect of methylprednisolone therapy on lipoprotein metabolism in human nephrotic syndrome.

Authors:  L Kuzemková; J Stríbrná; J Kovár; R Poledne; K Matousovic
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

2.  Lipoproteins and cholesterol homeostasis in paediatric nephrotic syndrome patients.

Authors:  Yonas Mulat Simachew; Tamara Antonić; Tamara Gojković; Sandra Vladimirov; Marija Mihajlović; Sanja Vujčić; Gordana Miloševski-Lomić; Jelena Vekić; Aleksandra Zeljković; Vesna Spasojević-Kalimanovska; Amira Peco-Antić; Dušan Paripović; Aleksandra Stefanović
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

3.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.